Fingerprint
Dive into the research topics of 'Nivolumab Monotherapy and Nivolumab Plus Ipilimumab in Recurrent Small Cell Lung Cancer: Results From the CheckMate 032 Randomized Cohort'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically